PT831791E - Entrega de farmacos ao tracto gi inferior - Google Patents
Entrega de farmacos ao tracto gi inferiorInfo
- Publication number
- PT831791E PT831791E PT96919237T PT96919237T PT831791E PT 831791 E PT831791 E PT 831791E PT 96919237 T PT96919237 T PT 96919237T PT 96919237 T PT96919237 T PT 96919237T PT 831791 E PT831791 E PT 831791E
- Authority
- PT
- Portugal
- Prior art keywords
- weight
- drug
- composition
- tract
- colon
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 4
- 229940079593 drug Drugs 0.000 title abstract 4
- 210000003750 lower gastrointestinal tract Anatomy 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 210000001072 colon Anatomy 0.000 abstract 2
- 208000019399 Colonic disease Diseases 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000416 hydrocolloid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/486,974 US5656294A (en) | 1995-06-07 | 1995-06-07 | Colonic delivery of drugs |
| US08/602,611 US5811388A (en) | 1995-06-07 | 1996-02-16 | Delivery of drugs to the lower GI tract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT831791E true PT831791E (pt) | 2005-02-28 |
Family
ID=27048854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96919237T PT831791E (pt) | 1995-06-07 | 1996-06-07 | Entrega de farmacos ao tracto gi inferior |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5811388A (pt) |
| EP (1) | EP0831791B1 (pt) |
| JP (1) | JPH11507357A (pt) |
| AT (1) | ATE280572T1 (pt) |
| AU (1) | AU6163096A (pt) |
| CA (1) | CA2224170A1 (pt) |
| DE (1) | DE69633721T2 (pt) |
| DK (1) | DK0831791T3 (pt) |
| ES (1) | ES2231815T3 (pt) |
| PT (1) | PT831791E (pt) |
| WO (1) | WO1996040078A1 (pt) |
Families Citing this family (98)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5612051A (en) * | 1995-11-17 | 1997-03-18 | Yue; Samuel K. | Method of treating involuntary muscle dysfunction with relaxin hormone |
| US6162464A (en) * | 1997-03-31 | 2000-12-19 | Inkine Pharmaceutical, Inc. | Non-aqueous colonic purgative formulations |
| ES2224428T3 (es) | 1997-09-26 | 2005-03-01 | Celltech Pharma Europe Limited | Composicion farmnaceutica para el tratamiento de la enfermedad inflmatoria intestinal. |
| GB9724186D0 (en) | 1997-11-14 | 1998-01-14 | British Tech Group | Low temperature coatings |
| EP1049486A4 (en) * | 1997-12-05 | 2006-01-04 | Lilly Co Eli | GLP-1 FORMULATIONS |
| US6251863B1 (en) | 1998-09-08 | 2001-06-26 | Samuel K. Yue | Method of preventing and treating symptoms of aging and neurodegenerative dysfunctions with relaxin |
| US8236352B2 (en) | 1998-10-01 | 2012-08-07 | Alkermes Pharma Ireland Limited | Glipizide compositions |
| US8293277B2 (en) * | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
| EP2266542A3 (en) * | 1998-10-01 | 2013-07-31 | Elan Pharma International Limited | Controlled release nanoparticulate compositions |
| CA2377301C (en) * | 1999-06-14 | 2009-05-12 | Cosmo S.P.A. | Controlled release and taste masking oral pharmaceutical compositions |
| US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| US6936275B2 (en) * | 1999-12-20 | 2005-08-30 | Scolr, Inc. | Amino acid modulated extended release dosage form |
| WO2003024427A1 (en) * | 1999-12-20 | 2003-03-27 | Temple University Of The Commonwealth System Of Higher Education | Tableted oral extended release dosage form |
| US7109303B2 (en) * | 2000-02-15 | 2006-09-19 | Fondazione Centro San Raffaele Del Monte Tabor | Modified cytokines for use in cancer therapy |
| IT1317835B1 (it) * | 2000-02-15 | 2003-07-15 | San Raffaele Centro Fond | Citochine modificate per uso nella terapia del cancro. |
| US7198795B2 (en) * | 2000-09-21 | 2007-04-03 | Elan Pharma International Ltd. | In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions |
| US20020123503A1 (en) * | 2000-12-21 | 2002-09-05 | Malcolm Ross | Cabergoline pharmaceutical compositions and methods of use thereof |
| AP1748A (en) * | 2001-03-13 | 2007-06-11 | Penwest Pharmaceuticals Co | Chronotherapeutic dosage forms. |
| US20070059368A1 (en) * | 2005-05-31 | 2007-03-15 | Cherukuri S R | Modified release formulations of anti-irritability drugs |
| DK1424997T3 (da) * | 2001-09-14 | 2008-01-07 | Scolr Inc | Aminosyremoduleret dosisform til forlænget frigivelse |
| ES2292848T3 (es) * | 2001-10-12 | 2008-03-16 | Elan Pharma International Limited | Composiciones que tienen una combinacion de caracteristicas de liberacion inmediata y liberacion controlada. |
| US7887838B2 (en) | 2002-01-18 | 2011-02-15 | Banner Pharmacaps, Inc. | Non-gelatin film and method and apparatus for producing same |
| US6949256B2 (en) * | 2002-01-18 | 2005-09-27 | Banner Pharmacaps, Inc. | Non-gelatin capsule shell formulation |
| GB0209896D0 (en) | 2002-04-30 | 2002-06-05 | Molmed Spa | Conjugate |
| GB0209893D0 (en) * | 2002-04-30 | 2002-06-05 | Molmed Spa | Conjugate |
| GB0216321D0 (en) * | 2002-07-13 | 2002-08-21 | Astrazeneca Ab | Therapeutic treatment |
| US20040023935A1 (en) * | 2002-08-02 | 2004-02-05 | Dey, L.P. | Inhalation compositions, methods of use thereof, and process for preparation of same |
| US20040106590A1 (en) * | 2002-08-29 | 2004-06-03 | Barry Eisenstein | Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| US20040091544A1 (en) * | 2002-11-08 | 2004-05-13 | Ruff Michael D. | Coated dibasic calcium phosphate |
| US7879833B2 (en) * | 2002-12-12 | 2011-02-01 | Nycomed Gmbh | Combination medicament |
| US20040142968A1 (en) * | 2003-01-17 | 2004-07-22 | Donald Price | Method and kit for treating lower bowel pain |
| GB0304194D0 (en) * | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
| US20050008677A1 (en) * | 2003-04-14 | 2005-01-13 | Fmc Corporation | Delivery system of homogeneous, thermoreversible gel film containing kappa-2 carrageenan |
| US20050013847A1 (en) * | 2003-04-14 | 2005-01-20 | Fmc Corporation | Delivery systems of homogeneous, thermoreversible alginate films |
| US20050019295A1 (en) * | 2003-04-14 | 2005-01-27 | Fmc Corporation | Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom |
| US20050019294A1 (en) * | 2003-04-14 | 2005-01-27 | Fmc Corporation | Homogeneous, thermoreversible alginate films and soft capsules made therefrom |
| JP2007525451A (ja) * | 2003-04-14 | 2007-09-06 | エフ エム シー コーポレーション | 均一かつ熱可逆性アルギネートフィルムの伝達システム |
| US7816341B2 (en) * | 2003-04-14 | 2010-10-19 | Fmc Corporation | Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom |
| US20050048185A1 (en) * | 2003-04-14 | 2005-03-03 | Fmc Corporation | Delivery systems of homogeneous, thermoreversible low viscosity polymannan gum films |
| KR101192722B1 (ko) | 2003-04-24 | 2012-10-18 | 자고텍 아게 | 정해진 핵 위치를 가지는 서방성 정제 |
| US20050147663A1 (en) * | 2003-07-17 | 2005-07-07 | Mohan Mailatur S. | Method of treatment for improved bioavailability |
| US20050042277A1 (en) * | 2003-07-17 | 2005-02-24 | Irukulla Srinivas | Pharmaceutical compositions having a swellable coating |
| US9149440B2 (en) * | 2003-09-02 | 2015-10-06 | University Of South Florida | Nanoparticles for drug-delivery |
| JP5371189B2 (ja) * | 2003-09-15 | 2013-12-18 | タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 炎症性腸疾患の治療のためのシクレソニドの使用 |
| PT1670482E (pt) * | 2003-09-16 | 2014-03-12 | Takeda Gmbh | Utilização de ciclesonida para o tratamento de doenças respiratórias |
| MXPA06003101A (es) | 2003-09-19 | 2006-06-20 | Penwest Pharmaceuticals Co | Formas de dosis cronoterapeuticas. |
| US8389008B2 (en) * | 2003-09-19 | 2013-03-05 | Penwest Pharmaceuticals Co. | Delayed release dosage forms |
| DE602004030931D1 (pt) * | 2003-11-04 | 2011-02-17 | Supernus Pharmaceuticals Inc | |
| US20070134165A1 (en) * | 2004-04-20 | 2007-06-14 | Altana Pharma Ag | Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient |
| AU2011232809B2 (en) * | 2004-09-10 | 2014-03-20 | Jagotec Ag | Tablets with site and time-controlled gastrointestinal release of active ingredient |
| DE102004043863A1 (de) * | 2004-09-10 | 2006-03-16 | Nitec Pharma Ag | Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum |
| AU2005281797B2 (en) * | 2004-09-10 | 2011-07-07 | Jagotec Ag | Tablets with site and time-controlled gastrointestinal release of active ingredient |
| US7799331B2 (en) * | 2005-08-04 | 2010-09-21 | Taro Pharmaceutical North America, Inc. | Oral suspension of prednisolone acetate |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| SI2049123T1 (sl) | 2006-08-03 | 2013-04-30 | Horizon Pharma Ag | Zdravljenje revmatoznih bolezni z zadržanim sproščanjem glukokortikoida |
| US20090036414A1 (en) * | 2007-08-02 | 2009-02-05 | Mutual Pharmaceutical Company, Inc. | Mesalamine Formulations |
| WO2010144865A2 (en) | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| EP2298321A1 (en) * | 2009-08-26 | 2011-03-23 | Nordic Pharma | Novel pharmaceutical compositions for treating IBD |
| EP2588112B1 (en) | 2010-06-30 | 2017-09-27 | Victoria Link Ltd | Methods and compositions for treatment of multiple sclerosis |
| ES2687027T3 (es) | 2010-11-04 | 2018-10-23 | Albireo Ab | Inhibidores de ibat para el tratamiento de enfermedades hepáticas |
| ME02874B (me) | 2010-12-22 | 2018-04-20 | Purdue Pharma Lp | Obloženi dozni oblici sa kontrolisanim oslobađanjem otporni na zloupotrebu |
| PH12013501345A1 (en) | 2010-12-23 | 2022-10-24 | Purdue Pharma Lp | Tamper resistant solid oral dosage forms |
| US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| MX2015010041A (es) | 2013-02-05 | 2015-10-30 | Purdue Pharma Lp | Formulacion farmaceuticas resistentes a la alteracion. |
| US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
| JO3301B1 (ar) | 2013-04-26 | 2018-09-16 | Albireo Ab | تعديلات بلورية على إيلوبيكسيبات |
| CN106659726A (zh) | 2014-06-25 | 2017-05-10 | Ea制药株式会社 | 固体制剂及其着色防止或着色减少方法 |
| EP3012252A1 (en) | 2014-10-24 | 2016-04-27 | Ferring BV | Crystal modifications of elobixibat |
| US10744070B2 (en) | 2015-06-19 | 2020-08-18 | University Of Southern California | Enteral fast access tract platform system |
| CA2990230A1 (en) | 2015-06-19 | 2016-12-22 | University Of Southern California | Compositions and methods for modified nutrient delivery |
| RS60237B1 (sr) | 2015-11-24 | 2020-06-30 | Theravance Biopharma R&D Ip Llc | Prolekovi jak inhibitornih jedinjenja za lečenje gastorintestinalne inflamatorne bolesti |
| CN108601739B (zh) | 2016-02-09 | 2022-01-04 | 阿尔比里奥公司 | 考来烯胺丸剂及其制备方法 |
| ES2874669T3 (es) | 2016-02-09 | 2021-11-05 | Albireo Ab | Formulación oral de colestiramina y uso de la misma |
| WO2017138878A1 (en) | 2016-02-09 | 2017-08-17 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| CN110418796A (zh) | 2017-03-08 | 2019-11-05 | 施万生物制药研发Ip有限责任公司 | 托法替尼(tofacitinib)的葡萄糖苷酸前药 |
| EP3609903A1 (en) | 2017-05-23 | 2020-02-19 | Theravance Biopharma R&D IP, LLC | Thiocarbamate prodrugs of tofacitinib |
| PH12019502605A1 (en) | 2017-05-23 | 2020-10-26 | Theravance Biopharma R&D Ip Llc | Glucuronide prodrugs of janus kinase inhibitors |
| CN111032019B (zh) | 2017-08-09 | 2022-07-05 | 阿尔比里奥公司 | 考来烯胺颗粒、口服考来烯胺制剂及其用途 |
| MX2020006886A (es) * | 2017-12-29 | 2020-11-11 | Laxxon Medical Ag | Sistema para suministro de medicamento. |
| CN112449637B (zh) | 2018-06-05 | 2024-03-19 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| PL3810581T3 (pl) | 2018-06-20 | 2025-04-28 | Albireo Ab | Modyfikacje kryształu odewiksibatu |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| TWI835997B (zh) | 2019-02-06 | 2024-03-21 | 瑞典商艾爾比瑞歐公司 | 苯并噻氮呯化合物及其用作膽酸調節劑之用途 |
| CN118852054A (zh) | 2019-02-06 | 2024-10-29 | 阿尔比里奥公司 | 苯并硫杂二氮杂环庚三烯化合物及其用作胆汁酸调节剂的用途 |
| EP4069247B1 (en) | 2019-12-04 | 2025-03-26 | Albireo AB | Benzothiadiazepine compounds and their use as bile acid modulators |
| JP7696898B2 (ja) | 2019-12-04 | 2025-06-23 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| ES2973355T3 (es) | 2019-12-04 | 2024-06-19 | Albireo Ab | Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar |
| IL293379B2 (en) | 2019-12-04 | 2026-04-01 | Albireo Ab | Benzothia(dia)azepine compounds and their use as bile acid modulators |
| EP4188541B1 (en) | 2020-08-03 | 2024-12-25 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
| CA3196488A1 (en) | 2020-11-12 | 2022-05-19 | Albireo Ab | Odevixibat for treating progressive familial intrahepatic cholestasis (pfic) |
| BR112023010799A2 (pt) | 2020-12-04 | 2023-10-03 | Albireo Ab | Compostos de benzotia(di)azepina e seus usos como moduladores de ácidos biliares |
| US20240293429A1 (en) * | 2021-06-01 | 2024-09-05 | Nbi Biosciences Pvt Ltd | Microbial-triggered oral intestinal drug delivery formulation and method of preparation thereof |
| TW202313579A (zh) | 2021-06-03 | 2023-04-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途 |
| WO2025235457A1 (en) | 2024-05-09 | 2025-11-13 | Alsteni Medical, Inc. | Intraoral gastrointestinal access device and related methods |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3629393A (en) * | 1969-09-11 | 1971-12-21 | Nikken Chemicals Co Ltd | Release-sustaining-tablet |
| GB1327938A (en) * | 1969-12-17 | 1973-08-22 | Sucrest Corp | Composition for use in forming tablets |
| DE2130545A1 (de) * | 1971-06-19 | 1972-12-21 | Merck Patent Gmbh | Pharmazeutischer Formkoerper |
| US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4894233A (en) * | 1984-10-05 | 1990-01-16 | Sharma Shri C | Novel drug delivery system for decongestants |
| EP0222883A1 (en) * | 1985-05-15 | 1987-05-27 | Riker Laboratories, Inc. | Sustained release theophylline compositions and processes |
| SE8601563D0 (sv) * | 1986-04-08 | 1986-04-08 | Carbomatrix Ab | Matrismaterial, forfarande for framstellning derav och anvendning derav |
| US4994276A (en) * | 1988-09-19 | 1991-02-19 | Edward Mendell Co., Inc. | Directly compressible sustained release excipient |
| US5466469A (en) * | 1988-06-28 | 1995-11-14 | Cibus Pharmaceutical, Inc. | Granular drug delivery system |
| CA1334379C (en) * | 1987-11-24 | 1995-02-14 | James William Mcginity | Method for preparing a solid sustained release form of a functionally active composition |
| US4999200A (en) * | 1987-12-09 | 1991-03-12 | Marion Laboratories | Psyllium tablet composition, method of manufacture and method of use |
| GB8812490D0 (en) * | 1988-05-26 | 1988-06-29 | Agricultural & Food Res | Delayed release formulations |
| US5096714A (en) * | 1988-06-28 | 1992-03-17 | Hauser-Kuhrts, Inc. | Prolonged release drug tablet formulations |
| US5445826A (en) * | 1988-06-28 | 1995-08-29 | Cibus Pharmaceutical, Inc. | Delivery system containing a gel-forming dietary fiber and a drug |
| US5128143A (en) * | 1988-09-19 | 1992-07-07 | Edward Mendell Co., Inc. | Sustained release excipient and tablet formulation |
| JP2683391B2 (ja) * | 1988-11-30 | 1997-11-26 | 日清製粉株式会社 | 小麦ふすまからのヘミセルロースを基材とする徐放性組成物 |
| US5130137A (en) * | 1989-08-09 | 1992-07-14 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders |
| GB8926639D0 (en) * | 1989-11-24 | 1990-01-17 | Agricultural & Food Res | Delayed release formulations |
| DE69131688T2 (de) * | 1990-05-04 | 2000-05-25 | Perio Products Ltd., Hahotzvim | System zur arzneistoffabgabe im colon |
| IL98087A (en) * | 1990-05-04 | 1996-11-14 | Perio Prod Ltd | Preparation for dispensing drugs in the colon |
| SE9002339L (sv) * | 1990-07-04 | 1992-01-05 | Kabi Pharmacia Ab | Terapeutisk komposition och foerfarande foer dess framstaellning |
| FR2667242B1 (fr) * | 1990-09-28 | 1994-11-25 | Rhone Poulenc Sante | Nouvelles formes orales a liberation prolongee avec un temps de latence au niveau stomacal amoindri. |
| ES2095894T3 (es) * | 1990-10-18 | 1997-03-01 | Basf Ag | Derivados de galactomanano para el revestimiento o la incrustacion de productos activos farmaceuticos. |
| US5422121A (en) * | 1990-11-14 | 1995-06-06 | Rohm Gmbh | Oral dosage unit form |
| DE9015551U1 (de) * | 1990-11-14 | 1992-03-12 | Röhm GmbH, 6100 Darmstadt | Orale Arzneiform und Überzugsmittel, enthaltend ein im Colon abbaubares Polysaccarid |
| AU5745394A (en) * | 1992-12-30 | 1994-08-15 | Fmc Corporation | Readily available konjac glucomannan sustained release excipient |
| CA2205351A1 (en) * | 1994-12-01 | 1996-06-06 | Cibus Pharmaceutical, Inc. | Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants |
| WO1996016639A1 (en) * | 1994-12-01 | 1996-06-06 | Cibus Pharmaceutical, Inc. | Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants |
| US5656294A (en) * | 1995-06-07 | 1997-08-12 | Cibus Pharmaceutical, Inc. | Colonic delivery of drugs |
-
1996
- 1996-02-16 US US08/602,611 patent/US5811388A/en not_active Expired - Fee Related
- 1996-06-07 AT AT96919237T patent/ATE280572T1/de not_active IP Right Cessation
- 1996-06-07 EP EP96919237A patent/EP0831791B1/en not_active Expired - Lifetime
- 1996-06-07 DK DK96919237T patent/DK0831791T3/da active
- 1996-06-07 ES ES96919237T patent/ES2231815T3/es not_active Expired - Lifetime
- 1996-06-07 WO PCT/US1996/009609 patent/WO1996040078A1/en not_active Ceased
- 1996-06-07 CA CA002224170A patent/CA2224170A1/en not_active Abandoned
- 1996-06-07 DE DE69633721T patent/DE69633721T2/de not_active Expired - Fee Related
- 1996-06-07 JP JP9501892A patent/JPH11507357A/ja active Pending
- 1996-06-07 PT PT96919237T patent/PT831791E/pt unknown
- 1996-06-07 AU AU61630/96A patent/AU6163096A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0831791A4 (en) | 1998-08-26 |
| AU6163096A (en) | 1996-12-30 |
| WO1996040078A1 (en) | 1996-12-19 |
| EP0831791A1 (en) | 1998-04-01 |
| US5811388A (en) | 1998-09-22 |
| ATE280572T1 (de) | 2004-11-15 |
| DK0831791T3 (da) | 2005-01-31 |
| EP0831791B1 (en) | 2004-10-27 |
| DE69633721T2 (de) | 2005-12-22 |
| DE69633721D1 (de) | 2004-12-02 |
| ES2231815T3 (es) | 2005-05-16 |
| CA2224170A1 (en) | 1996-12-19 |
| JPH11507357A (ja) | 1999-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT831791E (pt) | Entrega de farmacos ao tracto gi inferior | |
| DE69630460T2 (de) | Flurbiprofenhaltige arzneimittel | |
| JP2005515966A5 (pt) | ||
| RU98111594A (ru) | Фармацевтические композиции, включающие флурбипрофен | |
| NO940376L (no) | Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet | |
| DZ1884A1 (fr) | Formulations orales liquides d'alendronate. | |
| DE69306379D1 (de) | Inhalierbare arzneimittel | |
| MY125662A (en) | Pharmaceutical formulations containing darifenacin | |
| FR2727016B1 (fr) | Compositions pharmaceutiques a base d'ondansetron | |
| NO895167L (no) | Fremgangsmaate for behandling av tannrotsykdom ved vedvarende avgivelse av et farmasoeytisk middel til crevikularlommen, stoffblanding for dette og apparat for administrering derav. | |
| ATE261301T1 (de) | Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende arzneimittel | |
| IL139229A0 (en) | Drug delivery system comprising a tightly compacted solid medicament stock | |
| DE69101314D1 (de) | Dosierungsform zur verabreichung eines arzneimittels an die därme. | |
| KR950700056A (ko) | 분무-냉각된 나부메톤(Spray-chilled nabumetone) | |
| JP2002540148A5 (pt) | ||
| JP2003500446A (ja) | メラトニンの治療的使用法 | |
| NO974486L (no) | Lavdoserte "Ridogrel"-formuleringer samt anvendelse derav ved behandling av tarmbetennelse | |
| JPH08295637A (ja) | 口腔部局所投与剤 | |
| RU2006139819A (ru) | Применение симетикона для предрасположенных к запорам пациентов | |
| NO972486L (no) | Vedvarende frigjöring av legemiddel ved anvendelse av en pulverisert hydrokolloid-gummi som kan oppnås fra höyere planter | |
| JP2000500159A (ja) | メラトニンと組み合わせた鎮痛剤 | |
| Staquet et al. | Double-blind, randomized trial of piroxicam and codeine in cancer pain | |
| JPH01279818A (ja) | 白髪黒化剤 | |
| SU449724A1 (ru) | Отхаркивающее средство "мукалтин' | |
| JPH0967256A (ja) | 感冒薬 |